Factor D, upregulated by COVID-19 and involved in the alternative pathway, is correlated with markers of endothelial cell injury (e.g., angiotensin 2) and coagulation (e.g., vWF), possibly contributing to the association between COVID-19 and coagulopathy (21). The gene discussed is VWF; the disease is COVID-19.